Global Pharmacovigilance - Procurement Market Intelligence Report - ResearchAndMarkets.com

June 11, 2018

DUBLIN--(BUSINESS WIRE)--Jun 11, 2018--The “Global Pharmacovigilance - Procurement Market Intelligence Report” report has been added to ResearchAndMarkets.com’s offering.

Pharmacovigilance refers to the process where drugs are monitored for their effectiveness and safety. It helps in the identification and evaluation of any adverse reactions that might have previously gone undetected. Additionally, the demand for the category is being driven by the increasing incidence of ADEs, the rise in ADEs in the geriatric population, and the increase in investments by pharmaceutical companies toward the development of new drugs.

The report provides actionable insights to improve source-to-contract cycle performance in the Global Pharmacovigilance Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.

The report, Global Pharmacovigilance Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

Companies Mentioned

Accenture LabCorp IBM PAREXEL ICON

Key Topics Covered:

1: Category At A Glance

2: Scope Of The Report

3: Market Insights

4: Supply Market Insights

5: Pricing Insights

6: Procurement Insights

7: Top Five Suppliers

8: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/5cwn9z/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180611005510/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/11/2018 07:06 AM/DISC: 06/11/2018 07:06 AM


Update hourly